Codetta Bio™

October is Breast Cancer Awareness Month! As we honor Breast Cancer Awareness Month, we’re spotlighting the critical role that cytokines—IL-2, IL-4, IL-6, and IL-7—play in breast cancer development, progression, and treatment. Understanding these biomarkers can lead to new breakthroughs in therapy and diagnostics. Discover the Role of Cytokines in Breast Cancer Research: IL-2: Supports the activation of immune cells that can target and destroy cancer cells. IL-4: Linked to tumor growth by promoting a tumor-friendly environment and resistance to treatments. IL-6: A key player in inflammation, tumor growth, and metastasis, often linked to poor prognosis. IL-7: Helps tumor cells evade the immune system and promotes their survival and proliferation. Understanding the roles of these cytokines is critical for advancing breast cancer research and developing more effective therapies. That’s why we’re offering an exclusive opportunity to experience our advanced 4-plex cytokine assay for FREE! Want to explore how our assay can benefit your breast cancer research? Join us through our Technology Access Program (TAP) and be among the first to test our cutting-edge platform at no cost. Click here for more details: https://hubs.ly/Q02VFyTT0 #BreastCancerAwareness #CancerResearch #CodettaBio #TechnologyAccessProgram #BreastCancerResearch

Biomarker Discovery Professionals! Don’t miss this live event … Sign up now! https://lnkd.in/g95wT7ZJ

Webinar Treat: No Tricks, Just Insights! Join us on Oct 31 at 11:00 AM ET. Join us for an insightful session led by our assay development team as they walk you through our Codetta Bio platform. Codetta Bio combines the precision and depth of nucleic acid and protein analysis in a single, integrated solution. This innovative approach allows researchers to explore and analyze key molecular components side by side, creating a symphony of data and insights that drive discovery. Don’t miss this opportunity to learn about our versatile assays and how you can gain early access to our cutting-edge services. Click the link to sign up: https://hubs.ly/Q02TPM-10

We’re excited to announce a new collaboration and equity investment from RTI International! Together, we’re bringing cutting-edge technology to the forefront of precision medicine, driving innovation and advancing healthcare. “We are honored to welcome RTI International as both an investor and a strategic collaborator,” said Jacques Corriveau, CEO of Codetta Bio. “RTI’s global leadership in applying research to address critical real-world challenges aligns perfectly with our mission to innovate multiplex biomarker measurements for translational and clinical applications. Together, we believe we can have a profound impact on the future of precision medicine and healthcare.” https://hubs.ly/Q02Tq0zN0 Stay tuned for updates on how this partnership is set to transform the future of precision medicine! #HealthcareInnovation #PrecisionMedicine #Biomarkers

Join Our Webinar: Unlock the Future of Multiplex Innovation with TAP Are you ready to take your research to the next level? Join us for an exclusive, interactive webinar where we’ll explore the latest innovations in our Technology Access Program (TAP). Gain firsthand insights into our cutting-edge multiplex assay technology, designed to streamline complex analyses. Here’s what you’ll discover: -Explore groundbreaking technologies that deliver unmatched efficiency in detecting and quantifying multiple analytes simultaneously. -Learn how to gain early access to our technology access program, a powerful tool to accelerate your research. -Engage with our experts to discover how these technologies can significantly enhance your research impact. Date & Time: October 31, 11:00 ET Register Now: https://hubs.ly/Q02SJ_Gd0 We look forward to seeing you there!

Launch to New Heights! Why struggle with multiple instruments for digital and analog cytokine quantification, only to face the chaos of complex data analysis? Get ready to launch your research to new heights with Codetta's cutting-edge technology! With Codetta Bio, you get a combined solution—one platform that simplifies quantification and data analysis. Less hassle, more breakthroughs. Sign up now to learn more about our Early Access Program and be one of the first to experience this breakthrough! https://hubs.ly/Q02RZT7d0 #TechnologyAccessProgram #CytokineQuantification #CodettaBio #InnovativeResearch

Step Away from the Chaos! Why juggle different instruments for digital and analog cytokine quantification, only to face a data analysis nightmare? Codetta Bio offers a combined solution, simplifying both quantification and data analysis. One platform, less hassle. Ready to streamline your research? Learn more and try this breakthrough technology today! https://hubs.ly/Q02R4HJj0 #TechnologyAccessProgram #CytokineQuantification #CodettaBio #DigitalAndAnalog #InnovativeResearch

Exciting News! Yesterday, our CEO Jacques Corriveau had the opportunity to present at the North Carolina Biotechnology Center (NCBiotech) 40th Anniversary celebration, showcasing our groundbreaking technology at their Emerging Companies event. Want to learn how you can gain early access to our innovative solutions? Don’t miss out! Request more info today and discover how we’re transforming the future of biotech. Click here to learn more: https://lnkd.in/dD4Wsiwx #BiotechInnovation #NCBiotech #CodettaBio #TechnologyAccessProgram

How do you measure accurately across both high and low concentrations of target molecules in a single multiplex assay? Traditional methods often fall short, either lacking precision at lower concentrations or failing to handle high-target inputs effectively. But what if you didn’t have to choose between sensitivity and range? At Codetta Bio, we’ve developed a breakthrough approach that combines digital PCR and real-time PCR in a single sample. This dual-measurement system provides unparalleled accuracy across a wide range of concentrations. At higher target levels, we use real-time PCR to calculate CT values, while at lower concentrations, digital PCR kicks in to precisely measure target molecules by counting positive beads. This combination results in broad quantitative ranges in a single assay. See what you've been missing. Join the Technology Access Program to experience the technology. Learn more here: https://hubs.ly/Q02QhzrR0 #CodettaBio #multiplex #immunoassay #cytokines #TechnologyAccessProgram